COVID-19 Impact on Global Precision Cancer Diagnostic Tests Market Size, Status and Forecast 2020-2026

1 Report Overview

• 1.1 Study Scope
• 1.2 Key Market Segments
• 1.3 Players Covered: Ranking by Precision Cancer Diagnostic Tests Revenue
• 1.4 Market Analysis by Type
  • 1.4.1 Global Precision Cancer Diagnostic Tests Market Size Growth Rate by Type: 2020 VS 2026
  • 1.4.2 Imaging
  • 1.4.3 Molecular
  • 1.4.4 Histology/Cytology
  • 1.4.5 Tumor Marker Immunoassays
  • 1.4.6 POC Colon Cancer Tests
• 1.5 Market by Application
  • 1.5.1 Global Precision Cancer Diagnostic Tests Market Share by Application: 2020 VS 2026
  • 1.5.2 Hospital
  • 1.5.3 Clinic
  • 1.5.4 Other
• 1.6 Coronavirus Disease 2019 (Covid-19): Precision Cancer Diagnostic Tests Industry Impact
  • 1.6.1 How the Covid-19 is Affecting the Precision Cancer Diagnostic Tests Industry
    • 1.6.1.1 Precision Cancer Diagnostic Tests Business Impact Assessment - Covid-19
    • 1.6.1.2 Supply Chain Challenges
    • 1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
  • 1.6.2 Market Trends and Precision Cancer Diagnostic Tests Potential Opportunities in the COVID-19 Landscape
  • 1.6.3 Measures / Proposal against Covid-19
    • 1.6.3.1 Government Measures to Combat Covid-19 Impact
    • 1.6.3.2 Proposal for Precision Cancer Diagnostic Tests Players to Combat Covid-19 Impact
• 1.7 Study Objectives
• 1.8 Years Considered

2 Global Growth Trends by Regions

• 2.1 Precision Cancer Diagnostic Tests Market Perspective (2015-2026)
• 2.2 Precision Cancer Diagnostic Tests Growth Trends by Regions
  • 2.2.1 Precision Cancer Diagnostic Tests Market Size by Regions: 2015 VS 2020 VS 2026
  • 2.2.2 Precision Cancer Diagnostic Tests Historic Market Share by Regions (2015-2020)
  • 2.2.3 Precision Cancer Diagnostic Tests Forecasted Market Size by Regions (2021-2026)
• 2.3 Industry Trends and Growth Strategy
  • 2.3.1 Market Top Trends
  • 2.3.2 Market Drivers
  • 2.3.3 Market Challenges
  • 2.3.4 Porter’s Five Forces Analysis
  • 2.3.5 Precision Cancer Diagnostic Tests Market Growth Strategy
  • 2.3.6 Primary Interviews with Key Precision Cancer Diagnostic Tests Players (Opinion Leaders)

3 Competition Landscape by Key Players

• 3.1 Global Top Precision Cancer Diagnostic Tests Players by Market Size
  • 3.1.1 Global Top Precision Cancer Diagnostic Tests Players by Revenue (2015-2020)
  • 3.1.2 Global Precision Cancer Diagnostic Tests Revenue Market Share by Players (2015-2020)
  • 3.1.3 Global Precision Cancer Diagnostic Tests Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 3.2 Global Precision Cancer Diagnostic Tests Market Concentration Ratio
  • 3.2.1 Global Precision Cancer Diagnostic Tests Market Concentration Ratio (CR5 and HHI)
  • 3.2.2 Global Top 10 and Top 5 Companies by Precision Cancer Diagnostic Tests Revenue in 2019
• 3.3 Precision Cancer Diagnostic Tests Key Players Head office and Area Served
• 3.4 Key Players Precision Cancer Diagnostic Tests Product Solution and Service
• 3.5 Date of Enter into Precision Cancer Diagnostic Tests Market
• 3.6 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type (2015-2026)

• 4.1 Global Precision Cancer Diagnostic Tests Historic Market Size by Type (2015-2020)
• 4.2 Global Precision Cancer Diagnostic Tests Forecasted Market Size by Type (2021-2026)

5 Precision Cancer Diagnostic Tests Breakdown Data by Application (2015-2026)

• 5.1 Global Precision Cancer Diagnostic Tests Market Size by Application (2015-2020)
• 5.2 Global Precision Cancer Diagnostic Tests Forecasted Market Size by Application (2021-2026)

6 North America

• 6.1 North America Precision Cancer Diagnostic Tests Market Size (2015-2020)
• 6.2 Precision Cancer Diagnostic Tests Key Players in North America (2019-2020)
• 6.3 North America Precision Cancer Diagnostic Tests Market Size by Type (2015-2020)
• 6.4 North America Precision Cancer Diagnostic Tests Market Size by Application (2015-2020)

7 Europe

• 7.1 Europe Precision Cancer Diagnostic Tests Market Size (2015-2020)
• 7.2 Precision Cancer Diagnostic Tests Key Players in Europe (2019-2020)
• 7.3 Europe Precision Cancer Diagnostic Tests Market Size by Type (2015-2020)
• 7.4 Europe Precision Cancer Diagnostic Tests Market Size by Application (2015-2020)

8 China

• 8.1 China Precision Cancer Diagnostic Tests Market Size (2015-2020)
• 8.2 Precision Cancer Diagnostic Tests Key Players in China (2019-2020)
• 8.3 China Precision Cancer Diagnostic Tests Market Size by Type (2015-2020)
• 8.4 China Precision Cancer Diagnostic Tests Market Size by Application (2015-2020)

9 Japan

• 9.1 Japan Precision Cancer Diagnostic Tests Market Size (2015-2020)
• 9.2 Precision Cancer Diagnostic Tests Key Players in Japan (2019-2020)
• 9.3 Japan Precision Cancer Diagnostic Tests Market Size by Type (2015-2020)
• 9.4 Japan Precision Cancer Diagnostic Tests Market Size by Application (2015-2020)

10 Southeast Asia

• 10.1 Southeast Asia Precision Cancer Diagnostic Tests Market Size (2015-2020)
• 10.2 Precision Cancer Diagnostic Tests Key Players in Southeast Asia (2019-2020)
• 10.3 Southeast Asia Precision Cancer Diagnostic Tests Market Size by Type (2015-2020)
• 10.4 Southeast Asia Precision Cancer Diagnostic Tests Market Size by Application (2015-2020)

11 India

• 11.1 India Precision Cancer Diagnostic Tests Market Size (2015-2020)
• 11.2 Precision Cancer Diagnostic Tests Key Players in India (2019-2020)
• 11.3 India Precision Cancer Diagnostic Tests Market Size by Type (2015-2020)
• 11.4 India Precision Cancer Diagnostic Tests Market Size by Application (2015-2020)

12 Central & South America

• 12.1 Central & South America Precision Cancer Diagnostic Tests Market Size (2015-2020)
• 12.2 Precision Cancer Diagnostic Tests Key Players in Central & South America (2019-2020)
• 12.3 Central & South America Precision Cancer Diagnostic Tests Market Size by Type (2015-2020)
• 12.4 Central & South America Precision Cancer Diagnostic Tests Market Size by Application (2015-2020)

13 Key Players Profiles

• 13.1 Abbott Laboratories
  • 13.1.1 Abbott Laboratories Company Details
  • 13.1.2 Abbott Laboratories Business Overview and Its Total Revenue
  • 13.1.3 Abbott Laboratories Precision Cancer Diagnostic Tests Introduction
  • 13.1.4 Abbott Laboratories Revenue in Precision Cancer Diagnostic Tests Business (2015-2020))
  • 13.1.5 Abbott Laboratories Recent Development
• 13.2 Agilent Technologies
  • 13.2.1 Agilent Technologies Company Details
  • 13.2.2 Agilent Technologies Business Overview and Its Total Revenue
  • 13.2.3 Agilent Technologies Precision Cancer Diagnostic Tests Introduction
  • 13.2.4 Agilent Technologies Revenue in Precision Cancer Diagnostic Tests Business (2015-2020)
  • 13.2.5 Agilent Technologies Recent Development
• 13.3 Becton Dickinson and Company
  • 13.3.1 Becton Dickinson and Company Company Details
  • 13.3.2 Becton Dickinson and Company Business Overview and Its Total Revenue
  • 13.3.3 Becton Dickinson and Company Precision Cancer Diagnostic Tests Introduction
  • 13.3.4 Becton Dickinson and Company Revenue in Precision Cancer Diagnostic Tests Business (2015-2020)
  • 13.3.5 Becton Dickinson and Company Recent Development
• 13.4 Bio-Rad Laboratories
  • 13.4.1 Bio-Rad Laboratories Company Details
  • 13.4.2 Bio-Rad Laboratories Business Overview and Its Total Revenue
  • 13.4.3 Bio-Rad Laboratories Precision Cancer Diagnostic Tests Introduction
  • 13.4.4 Bio-Rad Laboratories Revenue in Precision Cancer Diagnostic Tests Business (2015-2020)
  • 13.4.5 Bio-Rad Laboratories Recent Development
• 13.5 Biocartis N.V.
  • 13.5.1 Biocartis N.V. Company Details
  • 13.5.2 Biocartis N.V. Business Overview and Its Total Revenue
  • 13.5.3 Biocartis N.V. Precision Cancer Diagnostic Tests Introduction
  • 13.5.4 Biocartis N.V. Revenue in Precision Cancer Diagnostic Tests Business (2015-2020)
  • 13.5.5 Biocartis N.V. Recent Development
• 13.6 Biocept
  • 13.6.1 Biocept Company Details
  • 13.6.2 Biocept Business Overview and Its Total Revenue
  • 13.6.3 Biocept Precision Cancer Diagnostic Tests Introduction
  • 13.6.4 Biocept Revenue in Precision Cancer Diagnostic Tests Business (2015-2020)
  • 13.6.5 Biocept Recent Development
• 13.7 bioMerieux SA
  • 13.7.1 bioMerieux SA Company Details
  • 13.7.2 bioMerieux SA Business Overview and Its Total Revenue
  • 13.7.3 bioMerieux SA Precision Cancer Diagnostic Tests Introduction
  • 13.7.4 bioMerieux SA Revenue in Precision Cancer Diagnostic Tests Business (2015-2020)
  • 13.7.5 bioMerieux SA Recent Development
• 13.8 Canon Medical Systems Corporation
  • 13.8.1 Canon Medical Systems Corporation Company Details
  • 13.8.2 Canon Medical Systems Corporation Business Overview and Its Total Revenue
  • 13.8.3 Canon Medical Systems Corporation Precision Cancer Diagnostic Tests Introduction
  • 13.8.4 Canon Medical Systems Corporation Revenue in Precision Cancer Diagnostic Tests Business (2015-2020)
  • 13.8.5 Canon Medical Systems Corporation Recent Development
• 13.9 Cynvenio Biosystems
  • 13.9.1 Cynvenio Biosystems Company Details
  • 13.9.2 Cynvenio Biosystems Business Overview and Its Total Revenue
  • 13.9.3 Cynvenio Biosystems Precision Cancer Diagnostic Tests Introduction
  • 13.9.4 Cynvenio Biosystems Revenue in Precision Cancer Diagnostic Tests Business (2015-2020)
  • 13.9.5 Cynvenio Biosystems Recent Development
• 13.10 Danaher Corporation
  • 13.10.1 Danaher Corporation Company Details
  • 13.10.2 Danaher Corporation Business Overview and Its Total Revenue
  • 13.10.3 Danaher Corporation Precision Cancer Diagnostic Tests Introduction
  • 13.10.4 Danaher Corporation Revenue in Precision Cancer Diagnostic Tests Business (2015-2020)
  • 13.10.5 Danaher Corporation Recent Development
• 13.11 Epigenomics AG
  • 10.11.1 Epigenomics AG Company Details
  • 10.11.2 Epigenomics AG Business Overview and Its Total Revenue
  • 10.11.3 Epigenomics AG Precision Cancer Diagnostic Tests Introduction
  • 10.11.4 Epigenomics AG Revenue in Precision Cancer Diagnostic Tests Business (2015-2020)
  • 10.11.5 Epigenomics AG Recent Development
• 13.12 Exosome Diagnostics
  • 10.12.1 Exosome Diagnostics Company Details
  • 10.12.2 Exosome Diagnostics Business Overview and Its Total Revenue
  • 10.12.3 Exosome Diagnostics Precision Cancer Diagnostic Tests Introduction
  • 10.12.4 Exosome Diagnostics Revenue in Precision Cancer Diagnostic Tests Business (2015-2020)
  • 10.12.5 Exosome Diagnostics Recent Development
• 13.13 Foundation Medicine
  • 10.13.1 Foundation Medicine Company Details
  • 10.13.2 Foundation Medicine Business Overview and Its Total Revenue
  • 10.13.3 Foundation Medicine Precision Cancer Diagnostic Tests Introduction
  • 10.13.4 Foundation Medicine Revenue in Precision Cancer Diagnostic Tests Business (2015-2020)
  • 10.13.5 Foundation Medicine Recent Development
• 13.14 General Electric Company
  • 10.14.1 General Electric Company Company Details
  • 10.14.2 General Electric Company Business Overview and Its Total Revenue
  • 10.14.3 General Electric Company Precision Cancer Diagnostic Tests Introduction
  • 10.14.4 General Electric Company Revenue in Precision Cancer Diagnostic Tests Business (2015-2020)
  • 10.14.5 General Electric Company Recent Development
• 13.15 Genomic Health
  • 10.15.1 Genomic Health Company Details
  • 10.15.2 Genomic Health Business Overview and Its Total Revenue
  • 10.15.3 Genomic Health Precision Cancer Diagnostic Tests Introduction
  • 10.15.4 Genomic Health Revenue in Precision Cancer Diagnostic Tests Business (2015-2020)
  • 10.15.5 Genomic Health Recent Development
• 13.16 Hologic
  • 10.16.1 Hologic Company Details
  • 10.16.2 Hologic Business Overview and Its Total Revenue
  • 10.16.3 Hologic Precision Cancer Diagnostic Tests Introduction
  • 10.16.4 Hologic Revenue in Precision Cancer Diagnostic Tests Business (2015-2020)
  • 10.16.5 Hologic Recent Development
• 13.17 Illumina
  • 10.17.1 Illumina Company Details
  • 10.17.2 Illumina Business Overview and Its Total Revenue
  • 10.17.3 Illumina Precision Cancer Diagnostic Tests Introduction
  • 10.17.4 Illumina Revenue in Precision Cancer Diagnostic Tests Business (2015-2020)
  • 10.17.5 Illumina Recent Development
• 13.18 Menarini Silicon Biosystems SpA
  • 10.18.1 Menarini Silicon Biosystems SpA Company Details
  • 10.18.2 Menarini Silicon Biosystems SpA Business Overview and Its Total Revenue
  • 10.18.3 Menarini Silicon Biosystems SpA Precision Cancer Diagnostic Tests Introduction
  • 10.18.4 Menarini Silicon Biosystems SpA Revenue in Precision Cancer Diagnostic Tests Business (2015-2020)
  • 10.18.5 Menarini Silicon Biosystems SpA Recent Development
• 13.19 Myriad Genetics
  • 10.19.1 Myriad Genetics Company Details
  • 10.19.2 Myriad Genetics Business Overview and Its Total Revenue
  • 10.19.3 Myriad Genetics Precision Cancer Diagnostic Tests Introduction
  • 10.19.4 Myriad Genetics Revenue in Precision Cancer Diagnostic Tests Business (2015-2020)
  • 10.19.5 Myriad Genetics Recent Development
• 13.20 NanoString Technologies
  • 10.20.1 NanoString Technologies Company Details
  • 10.20.2 NanoString Technologies Business Overview and Its Total Revenue
  • 10.20.3 NanoString Technologies Precision Cancer Diagnostic Tests Introduction
  • 10.20.4 NanoString Technologies Revenue in Precision Cancer Diagnostic Tests Business (2015-2020)
  • 10.20.5 NanoString Technologies Recent Development
• 13.21 Ortho Clinical Diagnostics
  • 10.21.1 Ortho Clinical Diagnostics Company Details
  • 10.21.2 Ortho Clinical Diagnostics Business Overview and Its Total Revenue
  • 10.21.3 Ortho Clinical Diagnostics Precision Cancer Diagnostic Tests Introduction
  • 10.21.4 Ortho Clinical Diagnostics Revenue in Precision Cancer Diagnostic Tests Business (2015-2020)
  • 10.21.5 Ortho Clinical Diagnostics Recent Development
• 13.22 QIAGEN N.V.
  • 10.22.1 QIAGEN N.V. Company Details
  • 10.22.2 QIAGEN N.V. Business Overview and Its Total Revenue
  • 10.22.3 QIAGEN N.V. Precision Cancer Diagnostic Tests Introduction
  • 10.22.4 QIAGEN N.V. Revenue in Precision Cancer Diagnostic Tests Business (2015-2020)
  • 10.22.5 QIAGEN N.V. Recent Development
• 13.23 Randox Laboratories Ltd.
  • 10.23.1 Randox Laboratories Ltd. Company Details
  • 10.23.2 Randox Laboratories Ltd. Business Overview and Its Total Revenue
  • 10.23.3 Randox Laboratories Ltd. Precision Cancer Diagnostic Tests Introduction
  • 10.23.4 Randox Laboratories Ltd. Revenue in Precision Cancer Diagnostic Tests Business (2015-2020)
  • 10.23.5 Randox Laboratories Ltd. Recent Development
• 13.24 Roche Holding AG
  • 10.24.1 Roche Holding AG Company Details
  • 10.24.2 Roche Holding AG Business Overview and Its Total Revenue
  • 10.24.3 Roche Holding AG Precision Cancer Diagnostic Tests Introduction
  • 10.24.4 Roche Holding AG Revenue in Precision Cancer Diagnostic Tests Business (2015-2020)
  • 10.24.5 Roche Holding AG Recent Development
• 13.25 Royal Philips N.V.
  • 10.25.1 Royal Philips N.V. Company Details
  • 10.25.2 Royal Philips N.V. Business Overview and Its Total Revenue
  • 10.25.3 Royal Philips N.V. Precision Cancer Diagnostic Tests Introduction
  • 10.25.4 Royal Philips N.V. Revenue in Precision Cancer Diagnostic Tests Business (2015-2020)
  • 10.25.5 Royal Philips N.V. Recent Development
• 13.26 Siemens AG
  • 10.26.1 Siemens AG Company Details
  • 10.26.2 Siemens AG Business Overview and Its Total Revenue
  • 10.26.3 Siemens AG Precision Cancer Diagnostic Tests Introduction
  • 10.26.4 Siemens AG Revenue in Precision Cancer Diagnostic Tests Business (2015-2020)
  • 10.26.5 Siemens AG Recent Development
• 13.27 Thermo Fisher Scientific
  • 10.27.1 Thermo Fisher Scientific Company Details
  • 10.27.2 Thermo Fisher Scientific Business Overview and Its Total Revenue
  • 10.27.3 Thermo Fisher Scientific Precision Cancer Diagnostic Tests Introduction
  • 10.27.4 Thermo Fisher Scientific Revenue in Precision Cancer Diagnostic Tests Business (2015-2020)
  • 10.27.5 Thermo Fisher Scientific Recent Development
• 13.28 Vela Diagnostics
  • 10.28.1 Vela Diagnostics Company Details
  • 10.28.2 Vela Diagnostics Business Overview and Its Total Revenue
  • 10.28.3 Vela Diagnostics Precision Cancer Diagnostic Tests Introduction
  • 10.28.4 Vela Diagnostics Revenue in Precision Cancer Diagnostic Tests Business (2015-2020)
  • 10.28.5 Vela Diagnostics Recent Development

14 Analyst's Viewpoints/Conclusions

15 Appendix

• 15.1 Research Methodology
  • 15.1.1 Methodology/Research Approach
  • 15.1.2 Data Source
• 15.2 Disclaimer